Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study - Concepedia

Concepedia

Publication | Open Access

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

DOI Full Paper Access

140

Citations

25

References

2018

Year

David M. Ross, Tamás Masszi, María Teresa Gómez‐Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentín García‐Gutiérrez, Norbert Gattermann, Philipp D. le Coutre, Bruno Martino,

Journal of Cancer Research and Clinical Oncology

References

	Year	Citations

Page 1